Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment

NCT02017496 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT02017496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02017496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Terminated
Start date
October 31, 2011
Completion date
December 31, 2015
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer